What ReMedys does – Who we are...

Board

The ReMedys Board monitors the running of the foundation, the distribution of ReMedys’ resources and the projects managed under the ReMedys umbrella.

The board consists of experienced professionals from different business areas to ensure that all foundation business and our diverse project portfolio is competently assessed and supervised.

Teresa Giovannini

President of the Board
Founding Partner at LALIVE Law Firm

Ms Giovannini specializes in international litigation and arbitration. She has acted as counsel and arbitrator in more than 150 international arbitrations.

Prof. Dr. med. Markus Weber

Board Member
Director of Muskelzentrum/ALS clinic , St. Gallen Cantonal Hospital, Switzerland

Dr. Weber is founder of the ALS clinic in St. Gallen in 2006 and the ALS clinic at the University Hospital Basel and acting chief of all ALS research projects in St. Gallen and Basel.

Dr. George Coukos

Board Member
Director of the Ludwig Cancer Research Center, Lausanne, and Director of the Department of Oncology at the University Hospital of Lausanne, Switzerland

Dr. Coukos is a recognized leader in cancer immunotherapy and tumor microenvironment research. His research focuses on understanding the immune system's response to ovarian cancer and other tumor types, and on developing therapies that enhance the immune response.

Dr. Bernard Schneider

Board Member
Research Associate, Swiss Federal Institute of Technology (EPFL) and Brain Mind Institute, Lausanne, Switzerland

Dr. Schneider is managing the Neurodegenerative Diseases Laboratory at the Brain Mind Institute and is a lecturer at the School of Life Sciences and the Doctoral Program in Neuroscience at the Swiss Federal Institute of Technology Lausanne (EPFL).

Dr. Michel Dreano

ReMedys Founder and Board Member

Dr. Dreano graduated from the University of Burgundy (PhD in Cell Biology) and from the University Paris 7/Institute Pasteur, France (PhD in Microbiology). He brings to the ReMedys more than 25 years professional experience in biotechnology and pharmaceuticals industry.